ArticleFrontiers in oncology2022

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer.

Peng-Fei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.